NuGen Medical Devices Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for NuGen Medical Devices Corp from these most-recent analyst ratings.
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
No data available to display |
There is no price target for NuGen Medical Devices
There is no analyst for NuGen Medical Devices
There is no last upgrade for NuGen Medical Devices
There is no last downgrade for NuGen Medical Devices.
There is no next analyst rating for NuGen Medical Devices.
There is no next analyst rating for NuGen Medical Devices.
Browse analyst ratings and price targets on all stocks.